Research on psychedelics has taken place for years at UC San Diego, but with the launch of the Psychedelics and Health Research Initiative (https://phri.ucsd.edu/) earlier this year, a new phase in the clinical study of psychedelics—to understand their basic mechanisms and their potential uses to treat chronic pain and other ailments—joins the national resurgence under the leadership of Mark Geyer and Adam Halberstadt. David Bronner, CEO of Dr. Bronner’s Magic Soaps (based in North County, San Diego), has been a longtime advocate and ally of the movement to re-examine the use of psychedelics, serving as a board member of MAPS (the Multidisciplinary Association for Psychedelic Studies) among other activities. We were pleased to organize this conversation between Mark, Adam, and David, hosted and moderated by Dr. Cassandra Vieten, about how the field has developed over the last ten years through the collaborative efforts of academic and private institutions, and what the future of psychedelic-assisted therapies may look like in the next ten years.

For more information, visit: https://phri.ucsd.edu/